Thyroid hormones contribute to JAK/STAT pathway abnormal activation, promoting T-cell lymphoma dissemination

Mercedes Debernardi(Consejo Nacional de Investigaciones Científicas y Técnicas), Florencia Cayrol(Cornell University), Ingrid L.M. Souza(Fundação Carlos Chagas), Leandro Cerchietti(Cornell University), Helena Sterle(Pontificia Universidad Católica Argentina), M Dávila(Hospital Británico de Buenos Aires), María V. Revuelta(Cornell University), Cinthia Rosemblit(Consejo Nacional de Investigaciones Científicas y Técnicas), Alejandro Correa(Fundação Carlos Chagas), Gonzalo Gonzalez(Pontificia Universidad Católica Argentina), Lucero Alvarado(Pontificia Universidad Católica Argentina), Graciela Cremaschi(Pontificia Universidad Católica Argentina), Jorgelina Nelly Real(Hospital Británico de Buenos Aires), Johanna Abigail Díaz Albuja(Pontificia Universidad Católica Argentina)
Blood Advances
June 9, 2025
10.1182/bloodadvances.2024015332
Cited by 1

Related Papers

THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors
|Nature Communications|2017|108
The metabolic adaptation evoked by arginine enhances the effect of radiation in brain metastases
|Science Advances|2021|42
Immunomodulatory role of histamine H4 receptor in breast cancer
|British Journal of Cancer|2018|35
Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies
|Oncotarget|2018|33
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell Lymphomas
|Cancer Research|2021|28